Journal of Psychopharmacology · 2018 · 32 citations · 68 references
MedicineNeurosciencePharmacologyNeuropharmacologyNeuropsychologyPsychopharmacologyBasal GangliaBasal Ganglia PhysiologyCannabinoid PharmacologyCannabis Use DisorderBasal Ganglia FunctionCannabinoid Effects On Motor FunctionCannabinoid Receptor PharmacodynamicsCannabinoid Receptor PharmacologyFinger Tapping TestPsychomotor ActivityPsychomotor Effects
BACKGROUND: Binding studies have demonstrated that levels of the cannabinoid receptor type-1 are highest in the basal ganglia and cerebellum, two areas critical for motor control. However, no studies have systematically examined the dose-related effects of intravenous delta-9-tetrahydrocannabinol, the primary cannabinoid receptor type-1 partial agonist in cannabis, on broad domains of psychomotor function in humans. AIMS: Therefore, three domains of psychomotor function were assessed in former cannabis users (cannabis abstinent for a minimum of three months; n=23) in a three test-day, within-subject, double-blind, randomized, cross-over, and counterbalanced study during which they received intravenous delta-9-tetrahydrocannabinol (placebo, 0.015 mg/kg, and 0.03 mg/kg). METHODS: Gross motor function was assessed via the Cambridge Neuropsychological Test Automated Battery Motor Screening Task, fine motor control via the Lafayette Instrument Grooved Pegboard task, and motor timing via a Paced Finger-Tapping Task. In addition, the Cambridge Neuropsychological Test Automated Battery Rapid Visual Processing Task was utilized to determine whether delta-9-tetrahydrocannabinol-induced motor deficits were confounded by disruptions in sustained attention. RESULTS/OUTCOMES: Delta-9-tetrahydrocannabinol resulted in robust dose-dependent deficits in fine motor control (Grooved Pegboard Task) and motor timing (Paced Finger-Tapping Task), while gross motor performance (Motor Screening Task) and sustained attention (Rapid Visual Processing Task) were unimpaired. Interestingly, despite the observed dose-dependent increases in motor impairment and blood levels of delta-9-tetrahydrocannabinol, subjects reported similar levels of intoxication in the two drug conditions. CONCLUSIONS/INTERPRETATION: These data suggest that while several domains of motor function are disrupted by delta-9-tetrahydrocannabinol, subjective feelings of intoxication are dissociable from cannabinoid-induced psychomotor effects. Results are discussed in terms of the potential neural mechanisms of delta-9-tetrahydrocannabinol in motor structures.
68
David Marr · The Journal of Physiology · 1969 · 3.3K citations
A theory of cerebellar function
James S. Albus · Mathematical Biosciences · 1971 · 2.6K citations
Cannabinoid receptor localization in brain.
Miles Herkenham, A B Lynn, M.D. Little et al. · Proceedings of the National Academy of Sciences · 1990 · 2.3K citations
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
K Tsou, Sean M. Brown, M.Clara Sañudo-Peña et al. · Neuroscience · 1998 · 1.6K citations